Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals

Journal of the American Pharmacists Association

Volumn 46, Issue 3, 2006, Pages 370-377

  Snella, Kathleen A ^a,c   Canales, Ann E ^b,c   Irons, Brian K ^c   Sleeper Irons, Rebecca B ^b,c   Villarreal, Maumi C ^c,d   Levi Derrick, Valerie E ^c,e   Greene, R Shane ^c,f   Jolly, Jamie L ^c,g   Nelson, Arthur A ^c,h  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d Biotech Pharmacy Inc   (United States)

^e Sankyo Pharma   (United States)

^f TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^g WINGATE UNIVERSITY   (United States)

^h TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cardiovascular disease; Community and ambulatory pharmacy; Diabetes mellitus; Dyslipidemia; Health screening; Hypertension

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ETHNICITY; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MASS SCREENING; PHARMACIST; PHARMACY; PHYSICIAN; RISK ASSESSMENT; RISK FACTOR; AFRICAN AMERICAN; AGED; CLINICAL TRIAL; FEMALE; HISPANIC; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGANIZATION AND MANAGEMENT; PROSPECTIVE STUDY; UNITED STATES;

AFRICAN AMERICANS; AGED; BLOOD GLUCOSE; COMMUNITY PHARMACY SERVICES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; UNITED STATES;

EID: 33745129740     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/154434506777069598     Document Type: Review

References (21)

1. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2000;23(suppl 1):S20-S23.
2. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2003;26(suppl 1):S21-S24.
3. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care. 2000;23:1563-80.
4. Hoerger TJ, Harris R, Hicks KA, et al. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med. 2004;140:689-99.
5. Grantmakers in Health. Strategies for reducing racial and ethnic disparities in health. Washington, D.C.: Grantmakers in Health; 2000:1-36.
6. California Medi-Cal Type 2 Diabetes Study Group. Closing the gap: effect of diabetes case management on glycemic control among low-income ethnic minority populations: the California Medi-Cal type 2 diabetes study. Diabetes Care. 2004;27:95-103.
7. U.S. Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Ann Intern Med. 2003;138:212-4.
8. Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects. J Am Pharm Assoc. 2003;43:50-5.
9. Gardner SF, Skelton DR, Rollins SD, Hastings JK. Community pharmacy data bases to identify patients at high risk for hypercholesterolemia. Pharmacotherapy. 1995;15:292-6.
10. Goode JV, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis. J Am Pharm Assoc. 2004;44:152-60.
11. Lata PF, Binkley NC, Elliott ME. Acceptability of pharmacy-based bone density measurement by women and primary healthcare providers. Menopause. 2002;9:449-55.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-23.
13. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-46.
14. Tabaei BP, Burke R, Constance A, et al. Community-based screening for diabetes in Michigan. Diabetes Care. 2003;26:668-70.
15. Newman WP, Nelson R, Scheer K. Community screening for diabetes. Low detection rate in a low-risk population. Diabetes Care. 1994;17:363-5.
16. Burge MR, Lucero S, Rassam AG, Schade DS. What are the barriers to medical care for patients with newly diagnosed diabetes mellitus? Diabetes Obes Metab. 2000;2:351-4.
17. Schwanberg SL. A nursing screening program for diabetes in northern New Mexico. Clin Excell Nurse Pract. 1999;3:15-8.
18. Edelman D, Edwards LJ, Olsen MK, et al. Screening for diabetes in an outpatient clinic population. J Gen Intern Med. 2002;17:23-8.
19. Weiner JP, Parente ST, Garnick DW, et al. Variation in office-based quality. A claims-based profile of care provided to Medicare patients with diabetes. JAMA. 1995;273:1503-8.
20. Andrus MR, Kelley KW, Murphey LM, Herndon KC. A comparison of diabetes care in rural and urban medical clinics in Alabama. J Community Health. 2004;29:29-44.
21. Krieger J, Collier C, Song L, Martin D. Linking community-based blood pressure measurement to clinical care: a randomized controlled trial of outreach and tracking by community health workers. Am J Public Health. 1999;89:856-61.